Arabic Arabic English English French French German German
dark

J&J’s HIV Vaccine Fails to Protect High-Risk African Women in Trial

Johnson & Johnson announced failed Imbokodo Phase IIb trial in HIV. The study evaluated the company’s investigational HIV vaccine regimen in young women in sub-Saharan Africa. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Medtech Incubators and Accelerators: Where Are the Hubs for Medical Device Innovation?

Next Post

Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows

Related Posts
Total
0
Share